T

Tomas G. Neilan

Albert Einstein College of Medicine

ORCID: 0000-0002-1513-8833

409 papers and 21.6k citations.

PubIndex Score98Top 2%How it's scored

409Publications

21.6kTotal Citations

First publication: 2005First senior author: 2007

Top publicationsby citations

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed Mahmood, Tomas G. Neilan, Michael G. Fradley et al.|Journal of the American College of Cardiology|2018

Cited by 1.5k

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Daniel J. Lenihan, Teresa López‐Fernández et al.|European Journal of Heart Failure|2020

Cited by 767

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann, Peter Valent, Daniel J. Lenihan et al.|European Heart Journal|2021

Cited by 589

Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque

Zsófia D. Drobni, Tomas G. Neilan, Sarah Hartmann et al.|Circulation|2020

Cited by 535

Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston Marathon

Tomas G. Neilan, Malissa J. Wood|Circulation|2006

Cited by 516

Indexing the rest of 409 publications…